Author: admin

MPA – How the Membrane Proteome Array Enabled Rapid Progression of a Neutralizing SARS-CoV-2 MAb

Integral Molecular In response to the COVID-19 pandemic, AboundBio developed potent neutralizing monoclonal antibodies (MAbs) against SARS-CoV-2. Read More […]

Live Tutorial: 6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins

Thursday, October 29, 2020 Watch video Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane proteins despite the […]

Totient Leverages Integral Molecular’s Membrane Proteome Array to Advance Cancer Therapeutic Discovery

PHILADELPHIA – Integral Molecular and Totient announce a partnership leveraging Integral Molecular’s Membrane Proteome Array (MPA) target identification technology to advance the discovery of […]

Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research

PHILADELPHIA – Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. Integral […]

Integral Molecular & Fierce Bio Present: De-risk Antibody and CAR-T Safety by Identifying Off-target Specificity Webinar

The long-held assumption that antibodies are exquisitely specific is being re-examined since 25% of monoclonal antibodies (MAbs) show polyspecificity and bind unintended targets. This […]

Humanized Chicken Antibody Technology to Drive Next Generation of Integral Molecular’s MPS Antibody Discovery Platform

PHILADELPHIA – Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company’s industry-leading MPS antibody […]

Science Center to Honor Leaders of Innovation Community at Annual Nucleus Awards

PHILADELPHIA–(August 20, 2020) – The University City Science Center will recognize three local leaders during its annual Nucleus Awards event on September 22, 2020, […]

Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications

WHITBECK ET AL. 2020. PLoS NEGL TROP DIS 14(11): e0008730. Read More […]

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection

WAICKMAN ET AL. 2020. EBIOMED 54:102733 Read More […]